Aa
A
A
Close
Blank
1569985 tn?1328251082
FDA Alert for Cardiac drug
New FDA Medwatch Alert
Sent to subscribers of: olmesartan systemic, olmesartan
Drug Safety Communication: Olmesartan Medoxomil - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
July 3, 2013
Audience: Health Professional, Cardiology, Patient.
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan. Read more.
More FDA Medwatch Alerts...
Cancel
0 Answers
0 Answers
Page 1 of 1
Your Answer
1569985 tn?1328251082
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Top Arrhythmias Answerers
1807132 tn?1318747197
Blank
MichelleP_3811
Chicago, IL
612551 tn?1450025775
Blank
Jerry_NJ
NJ
995271 tn?1408549100
Blank
itdood
PA
1423357 tn?1414258965
Blank
tom_h
Central, MA
12492606 tn?1459877633
Blank
researcher09
CA
Avatar f tn
Blank
CFS56
Recent Activity
370181 tn?1428180348
Blank
RubyWitch I am no longer accepting HI... Comment
21 hrs ago
1236893 tn?1408490528
Blank
Listeria Risk Triggers Huge Frozen ...
May 04 by gymdandee
463897 tn?1448485050
Blank
MH Community Mgr commented on Bubulous's status
May 03
Heart Rhythm Community Resources
Top Arrhythmias Answerers
1807132 tn?1318747197
Blank
MichelleP_3811
Chicago, IL
612551 tn?1450025775
Blank
Jerry_NJ
NJ
995271 tn?1408549100
Blank
itdood
PA
1423357 tn?1414258965
Blank
tom_h
Central, MA
12492606 tn?1459877633
Blank
researcher09
CA
Avatar f tn
Blank
CFS56